Brief: MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy
10/03/2026 09:40
March 10 (Reuters) - Mink Therapeutics Inc INKT.O: MINK THERAPEUTICS ANNOUNCES COLLABORATION WITH C-FURTHER TO ADVANCE PRAME-TARGETED INKT CELL THERAPY FOR PEDIATRIC CANCERS MINK THERAPEUTICS: CO TO RECEIVE $1.1 MILLION FUNDING FOR IND-ENABLING DEVELOPMENT OF ITS PRAME-TCR-INKT ASSET Source text: ID:nGNX1cxWkz Further company coverage: INKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's